Literature DB >> 26304503

Contemporary Management of Stone Disease: The New EAU Urolithiasis Guidelines for 2015.

Matthew Bultitude1, Daron Smith2, Kay Thomas3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26304503     DOI： 10.1016/j.eururo.2015.08.010

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  6 in total

1.  Diagnostic accuracy of dual-energy computed tomography (DECT) to differentiate uric acid from non-uric acid calculi: systematic review and meta-analysis.

Authors:  Trevor A McGrath; Robert A Frank; Nicola Schieda; Brian Blew; Jean-Paul Salameh; Patrick M M Bossuyt; Matthew D F McInnes
Journal:  Eur Radiol       Date:  2020-01-24       Impact factor: 5.315

2.  Current use of medical expulsive therapy among endourologists.

Authors:  Donald Charles Fedrigon; Rajat Jain; Sri Sivalingam
Journal:  Can Urol Assoc J       Date:  2018-05-14       Impact factor: 1.862

3.  The role of preoperative ureteral stenting in retrograde intrarenal surgery in renal stone patients: a propensity score-matched study.

Authors:  Luck Hee Sung; Dae Yeon Cho
Journal:  Transl Androl Urol       Date:  2020-04

4.  Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.

Authors:  Shen Song; I-Chun Thomas; Calyani Ganesan; Ericka M Sohlberg; Glenn M Chertow; Joseph C Liao; Simon Conti; Christopher S Elliott; Alan C Pao; John T Leppert
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-11       Impact factor: 10.614

5.  Comparison of the outcomes of laparoscopic pyeloplasty with and without concomitant pyelolithotomy.

Authors:  Mustafa Kadihasanoglu; Ugur Yucetas; Emre Karabay; Erkan Sonmezay
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

6.  The effect of preoperative ureteral stenting in retrograde Intrarenal surgery: a multicenter, propensity score-matched study.

Authors:  Hyeong Dong Yuk; Juhyun Park; Sung Yong Cho; Luck Hee Sung; Chang Wook Jeong
Journal:  BMC Urol       Date:  2020-09-14       Impact factor: 2.264
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.